Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online January 15, 2021.
Article Versions
- Latest version (April 25, 2020 - 04:00).
- You are currently viewing a Latest version of this article (January 15, 2021 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2021 The Journal of Rheumatology
Author Information
- Randy Q. Cron and
- W. Winn Chatham
- University of Alabama at Birmingham, Department of Pediatrics, Division of Rheumatology; University of Alabama at Birmingham, Department of Medicine, Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA.
Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin-1 blockade in treating secondary hemophagocytic lymphohistiocytosis (HLH) in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra.
Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI.
Address correspondence to Dr. R.Q. Cron, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, Suite G10, Birmingham, AL 35233-1711, USA. E-mail: rcron@peds.uab.edu.